IQ

Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

BBP vs GNOM: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, BBP returned +44.4% to GNOM's +66.6%; 12% of their weight is in the same names.

askIQ about this page

askIQ about BBP and GNOM

Net assets: $99m on Jul 31, 2026 for Virtus Biotech ETF, and $104m on Oct 12, 2026 for Global X Genomics & Biotechnology ETF.

BBP on its own →GNOM on its own →
At a glance
10.5%
BBP in the S&P 500
21.0%
GNOM in the S&P 500
+44.4%
BBP total return, 1 year
+66.6%
GNOM total return, 1 year
BBP · 1 year to Nov 4, 2026 90% of its weight is outside the S&P 500
90% of its weight is outside the S&P 50011% of BBP's weight is in S&P 500 companies and 90% is outside the index. Holdings as of Jul 31, 2026.11%90%inof its weight outside the S&P 500active share 99% · top ten 20% of the fund · 67 holdings as filed for Jul 31, 2026 · Nasdaq-100: 7% in90% of its weight is outside the S&P 50011% of BBP's weight is in S&P 500 companies and 90% is outside the index. Holdings as of Jul 31, 2026.11%90%inof its weight outside the S&P 500active share 99% · Nasdaq-100: 7% in

11% of BBP's weight is in S&P 500 companies and 90% is outside the index. Holdings as of Jul 31, 2026.

GNOM · 1 year to Nov 4, 2026 79% of its weight is outside the S&P 500
79% of its weight is outside the S&P 50021% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.21%79%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 49% of the fund · 50 holdings as filed for Aug 31, 2026 · Nasdaq-100: 5% in79% of its weight is outside the S&P 50021% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.21%79%inoutside the S&P 500active share 98% · Nasdaq-100: 5% in

21% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.

Pair scorecard

BBP costs 0.16 points a year less; their one-year returns differ by 22.2 points.

BBP vs GNOM: Holdings Overlap & Returns
MeasureBBPGNOM
Return
Total return, 1 year+44.4%+66.6%
Drawdown
Below its all-time high36.2%, high on Feb 8, 2021
Benchmark
What it tracksBiotechGenomics and gene editing
Cost and size
Expense ratio0.34%0.50%
Net assets, BBP as of Jul 31, 2026 and GNOM as of Oct 12, 2026$99m$104m
Holdings
Holdings in common12%

Method

What they share

12%

By the books each fund has filed, BBP and GNOM hold 12% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Aug 31, 2026.

0 half 100%

half

12% in common

Positions both hold · largest shared weight first BBP GNOM
ARROWHEAD PHARMACEUTICALS INC 1.56% 3.31%
MODERNA INC 1.51% 7.50%
VERTEX PHARMACEUTICALS INC 1.48% 3.70%
BIOMARIN PHARMACEUTICAL INC 1.48% 3.58%
GILEAD SCIENCES INC 1.43% 1.64%
BIONTECH SE 1.38% 2.78%
SAREPTA THERAPEUTICS INC 1.34% 1.63%
CRISPR THERAPEUTICS AG 1.33% 3.00%
LEGEND BIOTECH CORP 0.71% 2.38%
Only in one fund ↓
Only in BBP
CRINETICS PHARMACEUTICALS INC 3.34%
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC 1.97%
VERASTEM INC 1.95%
PRECIGEN INC 1.94%
OMEROS CORP 1.87%
NUVATION BIO INC 1.77%
REGENERON PHARMACEUTICALS 1.72%
PROTAGONIST THERAPEUTICS INC 1.71%
Only in GNOM
Twist Bioscience Corporation 6.34%
10x Genomics, Inc. 5.48%
GUARDANT HEALTH, INC. 5.28%
ILLUMINA, INC. 4.87%
NATERA, INC. 4.61%
Genscript Biotech Corp 3.81%
BIO-TECHNE CORPORATION 3.67%
Qiagen N.V. 3.22%
Check overlap with more funds →

Window by window

Window by window: BBP vs GNOM: Holdings Overlap & Returns
Total return
WindowBBPGNOM
3 months+8.8%+24.5%
6 months+16.6%+49.4%
1 year+44.4%+66.6%
3 years+113.7%+81.6%
Since launchNot the same days: BBP Dec 2014 · GNOM Apr 2019+310.5%+16.0%

Open this comparison in the app →

Side by side

BBP Virtus Biotech ETF · Holds 67 stocks in biotech, 10% of its weight in S&P 500 companies GNOM Global X Genomics & Biotechnology ETF · Holds 50 stocks in genomics and gene editing, 21% of its weight in S&P 500 companies
Issuer Virtus Global X
Theme Biotech Genomics and gene editing
In the S&P 500 10.5% 21.0%
Active share vs the S&P 500 99.0% 97.6%
In the Nasdaq-100 7.1% 5.3%
Holdings 67 50
Top ten, share of the fund 19.6% 48.8%
Expense ratio 0.34% 0.50%
Fee for the differing part 0.34% 0.51%
Total return, 1 year +44.4% +66.6%
vs its benchmark not measured not measured
Below its high −4.1% −36.2%
Net assets, BBP as of Jul 31, 2026 and GNOM as of Oct 12, 2026 $99m $104m

As of Nov 4, 2026. Source: ETFIQ.

12% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BBP

By weight, 10% of BBP's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 20% of the fund across 67 positions, as filed for Jul 31, 2026. Over the year to Nov 4, 2026 the fund returned +44.4% with distributions reinvested.

GNOM

By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 49% of the fund across 50 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +66.6% with distributions reinvested. It sits 36.2% below its all-time high of Feb 8, 2021.

Questions people ask

Do BBP and GNOM hold the same stocks?
By their latest filings, 12% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBP or GNOM?
BBP has 10% of its weight in S&P 500 names and GNOM has 21%, so BBP differs more from the index.
Which is cheaper, BBP or GNOM?
BBP charges 0.34% a year and GNOM charges 0.50%, so BBP is cheaper. Fees come from each fund's prospectus.
Other comparisons
BBP vs GNMXBBP vs IDNABBP vs ARKGBBP vs IBBQGNOM vs FBTGNOM vs XBIGNOM vs IBBGNOM vs IBBQ
Where to next
All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →BBP on its own →GNOM on its own →BBP holdings →GNOM dividend history →GNOM holdings →Method →Standards and sources →
Sources and dates
BBP filings on SEC EDGAR ↗
BBP prospectus with the expense ratio (SEC) ↗
Virtus website ↗
GNOM filings on SEC EDGAR ↗
GNOM prospectus with the expense ratio (SEC) ↗
Global X page for GNOM ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, BBP against GNOM, data as of Nov 4, 2026. https://etfiq.com/compare/themes/bbp-vs-gnom

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.